SCHEMBL9928150

SCHEMBL9928150

COc1cc2c(O)cc3c(c2c2c1N(F)CC2)-c1ccccc1C31CC(C)(C)CC(C)(C)C1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.34
PDK2 Q15119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9928154 0.95 PARP1 (0.33) PARP1
SCHEMBL9928151 0.91 PARP1 (0.34) PARP1
SCHEMBL9943081 0.89 PARP1 (0.33) PARP1PDK2
SCHEMBL9928155 0.87 PARP1 (0.33) PARP1
SCHEMBL9928187 0.81
SCHEMBL9928180 0.80 PARP1 (0.31) PARP1
SCHEMBL9928153 0.80 MTNR1A (0.32) PARP1
SCHEMBL9928179 0.79 PARP1 (0.33) PARP1
SCHEMBL9928156 0.79 PARP1 (0.30) PARP1
SCHEMBL9928161 0.79 PDE4D (0.40) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120145974-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2012-06-14 US disclosed
US-20120145974-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120145974-A1 CHROMENE COMPOUND CRY2, CYP2J2, NR0B2 PARP1 2140/4885PDK2 703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.